Editorial
doi: 10.1056/NEJM199709253371311.
Follow-up of patients with thyroid carcinoma
- PMID: 9302310
- DOI: 10.1056/NEJM199709253371311
Item in Clipboard
Editorial
Follow-up of patients with thyroid carcinoma
N Engl J Med.
.
No abstract available
Comment on
-
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.N Engl J Med. 1997 Sep 25;337(13):888-96. doi: 10.1056/NEJM199709253371304. N Engl J Med. 1997. PMID: 9302303 Clinical Trial.
Similar articles
-
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.N Engl J Med. 1997 Sep 25;337(13):888-96. doi: 10.1056/NEJM199709253371304. N Engl J Med. 1997. PMID: 9302303 Clinical Trial.
-
Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.Surg Oncol Clin N Am. 1998 Oct;7(4):665-80. Surg Oncol Clin N Am. 1998. PMID: 9735128 Review.
-
[Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].An Med Interna. 1988 Sep;5(9):439-43. An Med Interna. 1988. PMID: 2856622 Spanish. No abstract available.
-
[Rational basis for the therapy of differentiated carcinoma of the thyroid].Recenti Prog Med. 1984 Jul-Aug;75(7-8):758-74. Recenti Prog Med. 1984. PMID: 6438737 Review. Italian. No abstract available.
-
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.J Clin Endocrinol Metab. 1999 Nov;84(11):3877-85. doi: 10.1210/jcem.84.11.6094. J Clin Endocrinol Metab. 1999. PMID: 10566623 Clinical Trial.
Cited by
-
The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer.Rev Endocr Metab Disord. 2000 Apr;1(3):147-54. doi: 10.1023/a:1010018829345. Rev Endocr Metab Disord. 2000. PMID: 11705000 Review. No abstract available.
-
Differentiated thyroid cancer-personalized therapies to prevent overtreatment.Nat Rev Endocrinol. 2014 Sep;10(9):563-74. doi: 10.1038/nrendo.2014.100. Epub 2014 Jul 1. Nat Rev Endocrinol. 2014. PMID: 24981455 Review.
-
A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma.Medicine (Baltimore). 2015 Jul;94(28):e1191. doi: 10.1097/MD.0000000000001191. Medicine (Baltimore). 2015. PMID: 26181567 Free PMC article.
-
Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy.Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):499-506. doi: 10.1007/s00259-003-1405-9. Epub 2004 Jan 14. Eur J Nucl Med Mol Imaging. 2004. PMID: 14722676
-
The emerging role of pituitary tumor transforming gene in tumorigenesis.Clin Med Res. 2006 Jun;4(2):130-7. doi: 10.3121/cmr.4.2.130. Clin Med Res. 2006. PMID: 16809406 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
